Are we selling personalized medicine before its time?

Feb 06, 2009

We may be a long way off from using genetics to reliably gauge our risks for specific diseases, say researchers at the University of Pittsburgh Graduate School of Public Health in a study published on Feb. 5 in the online journal PLoS Genetics. Yet, many companies currently offer personalized genetic testing for diseases like cancer, heart disease and diabetes, and tout the ability of DNA testing to predict future health risks.

"The rapid discovery of new genetic risk factors is giving us vitally important insights into human health, but a strong association between these factors and disease risk may not reliably predict which health issues a specific individual will face in the future," said Daniel E. Weeks, Ph.D., senior author and professor of human genetics and biostatistics at the University of Pittsburgh Graduate School of Public Health. "Our study indicates that even though we can paint a picture of our genetic makeup with current tests, this may not be enough to help us understand our individual risk for disease."

The study focused on single nucleotide polymorphisms, or SNPs - variations in short DNA sequences that have been linked to the presence of particular diseases, and that exist in the millions in the human genome. A number of companies currently offer individualized estimates for disease risks based on genome-wide SNP genotyping. These tests typically scan 500,000 to 1 million SNPs, searching for only a handful associated with a specific disease.

Dr. Weeks and colleagues focused their study on diseases for which there are strongly associated genetic variants: age-related macular degeneration, type 2 diabetes, prostate cancer, cardiovascular disease and Crohn's disease. They found that a strong genetic association did not guarantee they could accurately discriminate between actual disease cases and controls in both mathematical models and real-world examples.

Part of the problem may be a statistical one. To provide meaningful insights, a test for disease risk needs to accurately identify positive cases and, at the same time, provide a low false positive rate. One of the challenges with current approaches to genetic testing is that they are based on a very small number of common variants, "making it likely that you will identify people at high risk who may not be at risk at all," said Dr. Weeks. "With such a small pool of variants, it's difficult to develop a very meaningful test for predicting disease risk."

In addition, he said, few health care providers have adequate genetics training to make sense of the risk calculations now commercially offered and to advise their patients accordingly.

Dr. Weeks suggests the need for longitudinal studies to define true risk and to understand how genetic susceptibility may interact with known environmental and lifestyle risk factors.

"With more study, our hope is that genetic testing will benefit people and encourage positive lifestyle changes and guide clinical decisions. In the meantime, we need to take a step back and proceed with caution and allow the insights gained from these new association findings to be used to explore the basic biological causes of disease," he said.

Source: University of Pittsburgh Schools of the Health Sciences

Explore further: Americans rate losing eyesight as having greatest impact on their lives

add to favorites email to friend print save as pdf

Related Stories

Congress: Safety agency mishandled GM recall

12 minutes ago

Both houses of Congress scolded the U.S. highway safety agency Tuesday over its tardy handling of a deadly problem with General Motors cars, questioning whether it is competent to guarantee the safety of ...

Alibaba post-IPO structure gives insiders control

22 minutes ago

Control over Alibaba Group will stay in the hands of founder Jack Ma and other company veterans after the Chinese e-commerce giant goes public on the New York Stock Exchange in a record busting share sale.

New Apple mobile software arrives Wednesday

42 minutes ago

New-generation Apple software for powering its coveted mobile devices is set for release on Wednesday, two days ahead of the arrival of its latest iPhones.

Recommended for you

ER waiting times vary significantly, studies find

1 hour ago

(HealthDay)—When it comes to emergency room waiting times, patients seeking care at larger urban hospitals are likely to spend more time staring down the clock than those seen at smaller or more rural facilities, ...

Internists report considerable EMR-linked time loss

2 hours ago

(HealthDay)—Use of electronic medical record (EMR) systems is associated with considerable loss of free time per clinic day, according to a research letter published online Sept. 8 in JAMA Internal Medicine.

Kids eat better if their parents went to college

2 hours ago

Children of college-educated parents eat more vegetables and drink less sugar, according to a new study from the University of British Columbia. But it's still not enough, the study goes on to say, as all kids are falling ...

User comments : 0